Increasingly , interest is developing within the UK regarding the drug as a viable solution for fat distribution issues . While largely recent, knowledge of what it can do – particularly in addressing the consequences of HIV-related fat wasting – is expanding . Clinicians are researching its suitability, and interest from individuals is growin